A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

NCT05379595 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Colorectal Cancer

Interventions

BIOLOGICAL: Amivantamab IV
BIOLOGICAL: Fluorouracil
BIOLOGICAL: Leucovorin
BIOLOGICAL: Oxaliplatin
BIOLOGICAL: Irinotecan
BIOLOGICAL: Amivantamab

Sponsor

Janssen Research & Development, LLC